With New Around-the-Clock Axes, Practitioners Can Fit Majority of Your Astigmatic Patients in Premium Silicone Hydrogel 1-Day Toric Contact Lenses
RICHMOND HILL, ON., Jun 30, 2021— To provide eye care professionals the opportunity to fit an even greater number of astigmatic patients in a premium silicone hydrogel 1-day contact lens, CooperVision has announced expanded prescriptions for MyDay® toric in Canada. The lenses are now available in around-the-clock axes1 in the most commonly prescribed sphere powers.
“CooperVision is known around the world for our toric contact lens innovation and performance. The addition of new MyDay® toric prescription options expands our commitment to providing a wide range of stable fit, comfortable silicone hydrogel 1-day toric options for astigmatic patients,” said Amy Chow, Professional Affairs Manager, Canada. “And for practitioners who know and love Biofinity® toric, they have the flexibility to offer their patients those ocular benefits replicated in a 1-day lens—it’s the features of one optic design with two options.”
CooperVision’s MyDay® toric lenses combine the proven optic design features of Biofinity® toric with the premium silicone hydrogel 1-day material of MyDay®. This revered toric technology, called Optimized Toric Lens Geometry™, provides uniform horizontal ISO thickness, an optimized ballast band design, a large toric optic zone, and a smooth, continuous surface to make it an easy-to-fit, stable toric lens. In addition, the MyDay® family of lenses is made with Aquaform® Technology, which locks moisture into the lens and keeps it soft for a comfortable lens-wearing experience. This natural wettability can help wearers’ eyes feel less dry without coatings or surface treatments. And while the lens provides optimal comfort, it remains strong enough to ensure exceptional handling. 2,3† MyDay® toric’s built-in UV blocker filters 85% of UVA and 96% of UVB rays*.
Eye care professionals will be able to fit a greater number of 1-day toric patients in MyDay® toric with the addition of the following prescription options (in bold):
|
Sphere Power (DS) |
Cylinder Power |
Axes ° |
|
Plano to -6.00D (0.25D steps) |
-0.75, -1.25, -1.75 |
10, 20, 30, 40, 50, 60, 70, 80, 90, 100, 110, 120, 130, 140, 150, 160, 170, 180 |
|
Plano to -6.00D (0.25D steps) -6.50D to -10.00D (0.50D steps) +0.50D to +6.00D (0.50D steps) |
-2.25 |
10, 20, 90, 160, 170 and 180 |
|
-6.50D to -10.00D (0.50D steps) +0.25D to +6.00D (0.25D steps)
|
-0.75, -1.25, -1.75 |
10, 20, 70, 80, 90, 100, 110, 160, 170, 180 |
To help streamline the fitting process and save valuable chair time, CooperVision also offers the OptiExpert™ fitting app. The app is an essential tool for your practice, designed to speed up contact lens selection4,5,, save you time on toric and multifocal fittings5,6 and make your patient’s experience better than ever.
For more information about MyDay® toric, visit https://coopervision.ca/practitioner/our-products/myday-family/myday-toric
* Warning: UV-absorbing contact lenses are not substitutes for protective UV-absorbing eyewear, such as UV-absorbing goggles or sunglasses, because they do not completely cover the eye and surrounding area. Patients should continue to use UV-absorbing eyewear as directed.
† CVI SiHy toric products with Optimized Toric Lens Geometry™ are compared individually to at least one of the listed products as follows: Biofinity® toric and Avaira Vitality® toric vs. Acuvue Oasys for Astigmatism, Acuvue Vita for Astigmatism, Air Optix for Astigmatism and Ultra for Astigmatism; MyDay® toric vs. 1-Day Acuvue Moist for Astigmatism.
1. Around the clock axis in 10° from Plano to -6.00D in -0.75DC, 1.25DC and -1.75DC.
2. CVI data on file 2020; review of performance 9 soft toric CL studies with Optimized Toric Lens Geometry™ lenses; n=383.
3. Stifel (equity research firm) 2013, 21 UK practitioners surveyed comparing performance of MyDay with other silicone hydrogel daily disposables.
4. Based on use with Biofinity® toric, MyDay® toric and clariti® 1 day toric lenses.
5. Luensmann D et al. Toric lens fitting success supported by an online fitting App. Poster to be presented at NCC/BCLA 2020.
6. CVI data on file 2019. Retrospective analysis; N=55 subjects (110 eyes); DV Rx +1.25D to -3.25D, add powers +1.25 to +2.50DS.
# # #
About CooperVision
CooperVision, a division of CooperCompanies (NYSE:COO), is one of the world’s leading manufacturers of contact lenses. The company produces a full array of daily disposable, two-week and monthly soft contact lenses that feature advanced materials and optics, and premium rigid gas permeable lenses for orthokeratology and scleral designs. CooperVision has a strong heritage of addressing the toughest vision challenges such as astigmatism, presbyopia, childhood myopia, and highly irregular corneas; and offers the most complete portfolio of spherical, toric and multifocal products available. Through a combination of innovative products and focused practitioner support, the company brings a refreshing perspective to the marketplace, creating real advantages for customers and wearers. For more information, visit www.coopervision.com.
About CooperCompanies
CooperCompanies ("Cooper") is a global medical device company publicly traded on the NYSE (NYSE:COO). Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of women, babies and families with its diversified portfolio of products and services focusing on medical devices and fertility & genomics. Headquartered in San Ramon, Calif., Cooper has a workforce of more than 12,000 with products sold in over 100 countries. For more information, please visit www.coopercos.com.
Media Contact
Heather Kowalczyk
McDougall Communications for CooperVision, Inc.
heather@mcdougallpr.com or +1-585-434-2148